The Patent Finder

Amneal Complex Products Research LLC

48 patents currently held · Updated Nov 20, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

Previously recorded as Kashiv Specialty Pharmaceuticals, LLC (to 2021)

0
Ending by 2030
Jun 2033
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 6 to 27, 2026 · next Dec 6
  • 1 fee due Mar 10, 2027
    The maintenance fee for Method of Manufacturing Fine Particles Suitable for Orally Disintegrating Pharmaceutical Dosage Forms (US 10,406,234) comes due Mar 10, 2027. Unpaid by Sep 10, 2027, it lapses early.
  • 1 fee due Apr 24, 2027
    The maintenance fee for Self-regulating osmotic gastroretentive drug delivery systems (US 11,793,747) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.
  • 1 fee due Jun 10, 2027
    The maintenance fee for Supersaturated Stabilized Nanoparticles for Poorly Soluble Drugs (US 10,500,282) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.
  • 1 fee due Aug 27, 2027
    The maintenance fee for Extended release compositions comprising pyridostigmine (US 11,911,515) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
  • 1 fee due Sep 17, 2027
    The maintenance fee for Extended Release Compositions Comprising Pyridostigmine (US 10,588,863) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
  • 2 fees due Oct 23 to 28, 2027 · next Oct 23

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 22, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,884,173Medicament Applicator
In force
 · Medium confidence
In forceMedium confidence
US 10,500,282Supersaturated Stabilized Nanoparticles for Poorly Soluble Drugs
In force
 · High confidence
In forceHigh confidence
US 10,195,150Orally Disintegrating Tablet Formulation for Enhanced Bioavailability
In force
 · High confidence
In forceHigh confidence
US 9,511,078Self-Nanoemulsion of Poorly Soluble Drugs
In force
 · High confidence
In forceHigh confidence
US 10,940,300Medicament Applicator
In force
 · High confidence
In forceHigh confidence
US 10,632,113Abuse-Resistant Drug Formulations with Built-In Overdose Protection
In force
 · High confidence
In forceHigh confidence
US 10,406,234Method of Manufacturing Fine Particles Suitable for Orally Disintegrating Pharmaceutical Dosage Forms
In force
 · High confidence
In forceHigh confidence
US 9,517,328Medicament Applicator
In force
 · High confidence
In forceHigh confidence
US 10,744,131Abuse-Resistant Drug Formulations
In force
 · High confidence
In forceHigh confidence
US 10,034,865Surfactant-Free HIV Protease Inhibitor Composition and Method of Manufacturing Thereof
In force
 · High confidence
In forceHigh confidence
10 of 48 patents shown.
Pro members see all 48.
Pro members: see all 48 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 abandoned · 7 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited